Correlation Between Eupraxia Pharmaceuticals and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and Purple Biotech, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Purple Biotech.
Diversification Opportunities for Eupraxia Pharmaceuticals and Purple Biotech
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eupraxia and Purple is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Purple Biotech go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Purple Biotech
Assuming the 90 days horizon Eupraxia Pharmaceuticals is expected to generate 0.78 times more return on investment than Purple Biotech. However, Eupraxia Pharmaceuticals is 1.28 times less risky than Purple Biotech. It trades about -0.03 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.1 per unit of risk. If you would invest 396.00 in Eupraxia Pharmaceuticals on August 24, 2024 and sell it today you would lose (117.00) from holding Eupraxia Pharmaceuticals or give up 29.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 52.4% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals vs. Purple Biotech
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Purple Biotech |
Eupraxia Pharmaceuticals and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Purple Biotech
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Eliem Therapeutics |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |